NO20034679L - Fremgangsmåte ved opprensning av 6-metoksyomeprazol - Google Patents

Fremgangsmåte ved opprensning av 6-metoksyomeprazol

Info

Publication number
NO20034679L
NO20034679L NO20034679A NO20034679A NO20034679L NO 20034679 L NO20034679 L NO 20034679L NO 20034679 A NO20034679 A NO 20034679A NO 20034679 A NO20034679 A NO 20034679A NO 20034679 L NO20034679 L NO 20034679L
Authority
NO
Norway
Prior art keywords
methoxyomeprazole
purifying
Prior art date
Application number
NO20034679A
Other languages
English (en)
Other versions
NO20034679D0 (no
Inventor
Linda Whittal
Grayson Walker Stowell
Robert R Whittle
Original Assignee
Aai Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/839,395 external-priority patent/US6673936B2/en
Priority claimed from US09/839,449 external-priority patent/US6608091B2/en
Application filed by Aai Pharma Inc filed Critical Aai Pharma Inc
Publication of NO20034679L publication Critical patent/NO20034679L/no
Publication of NO20034679D0 publication Critical patent/NO20034679D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20034679A 2001-04-20 2003-10-20 Fremgangsmåte ved opprensning av 6-metoksyomeprazol NO20034679D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/839,395 US6673936B2 (en) 2001-04-20 2001-04-20 Process for purifying 6-methoxy omeprazole
US09/839,449 US6608091B2 (en) 2001-04-20 2001-04-20 Process for purifying 6-methoxy omeprazole
PCT/US2002/015254 WO2002085312A2 (en) 2001-04-20 2002-04-17 Process for purifying 6-methoxy omeprazole

Publications (2)

Publication Number Publication Date
NO20034679L true NO20034679L (no) 2003-10-20
NO20034679D0 NO20034679D0 (no) 2003-10-20

Family

ID=27126104

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034679A NO20034679D0 (no) 2001-04-20 2003-10-20 Fremgangsmåte ved opprensning av 6-metoksyomeprazol

Country Status (8)

Country Link
EP (1) EP1379518A2 (no)
JP (1) JP2004528331A (no)
KR (1) KR20030088506A (no)
CN (1) CN100503596C (no)
CA (1) CA2443605A1 (no)
HU (1) HUP0304004A2 (no)
NO (1) NO20034679D0 (no)
WO (1) WO2002085312A2 (no)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0204215B1 (en) * 1985-05-24 1993-08-11 G.D. Searle & Co. 2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-benzenamines
AU6937700A (en) * 1999-08-26 2001-03-19 Applied Analytical Industries, Inc. Ft-raman spectroscopic measurement of omeprazole isomer ratio in a composition

Also Published As

Publication number Publication date
HUP0304004A2 (hu) 2004-04-28
WO2002085312A2 (en) 2002-10-31
KR20030088506A (ko) 2003-11-19
CN1503791A (zh) 2004-06-09
CN100503596C (zh) 2009-06-24
EP1379518A2 (en) 2004-01-14
NO20034679D0 (no) 2003-10-20
JP2004528331A (ja) 2004-09-16
CA2443605A1 (en) 2002-10-31
WO2002085312A3 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
NO20025814L (no) Fremgangsmåte ved brönnfullföring
NO20035426D0 (no) Fremgangsmåte ved administrering av anti-TNF-D-antistoff
DE60221619D1 (de) Verfahren zur Reinigung von Synthesegas
NO20023928L (no) Fremgangsmåte ved fremstillingen av citalopram
NO20024007L (no) Fremgangsmåte ved fremstillingen av citalopram
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
DE60218451D1 (de) 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
NO20040292L (no) Fremgangsmate for fremstilling av 4-aminodifenylamin
NO20024180L (no) Fremgangsmåte ved fremstillingen av citalopram
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
NO20024213L (no) FremgangsmÕte ved fremstilling av citalopram
NO20015766D0 (no) Fremgangsmåte ved oljeproduksjon
NO20035136D0 (no) Fremgangsmåte til fremstilling av imipenem
NO20024214D0 (no) Fremgangsmåte ved fremstilling av citalopram
FI20010472A0 (fi) Menetelmä alfa-pineenin hydraamiseksi
NO20034679L (no) Fremgangsmåte ved opprensning av 6-metoksyomeprazol
NO20043935L (no) Fremgangsmåte ved fremstilling av interferon
NO20024678D0 (no) Fremgangsmåte ved selektiv N-formylering av N-hydroksylaminer
NO20011136L (no) Fremgangsmåte ved byggbehandling
NO20034972D0 (no) Behandling av ADHD
NO20041193L (no) Fremgangsmåte til fremstilling av beta-ionylidenacetaldehyd
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20022643D0 (no) Reduksjonsprosess
FI20011469A (fi) Savukaasujen puhdistusprosessi
NO20003044L (no) Fremgangsmåte ved fremstilling av prosessolje

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application